[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Shay Boloor [@StockSavvyShay](/creator/twitter/StockSavvyShay) on x 198.7K followers Created: 2023-11-09 13:53:58 UTC Medtech stock have recently seen a sharp drawdown due to all the noise regarding the anti-obesity drug Ozempic -- let's delve into my "Starting 5' names along with their competitive moats & examine where they stand based on 2025 FCF multiple🤔 X. $INSP (Inspire Medical Systems) • Competitive Advantage: Dominates the niche market of sleep apnea treatment through innovative technology. Their Inspire therapy, a unique neurostimulation device, directly targets the patient market dissatisfied with or ineligible for CPAP machines, creating a significant market opportunity in sleep disorder treatment. X. $ISRG (Intuitive Surgical) • Competitive Advantage: Leads in the robotic-assisted surgery market with its da Vinci Surgical System. This technology offers hospitals and surgical centers a competitive edge through enhanced precision and minimally invasive procedures, leading to better patient outcomes and potentially shorter hospital stays. X. $PGNY (Progyny) • Competitive Advantage: Carves a unique niche in the fertility benefits management sector. By offering integrated fertility and family planning services, Progyny appeals to a growing corporate client base seeking to provide comprehensive health benefits, thereby tapping into a growing market demand for inclusive healthcare benefits. X. $SWAV (Shockwave Medical) • Competitive Advantage: Innovates in the calcified plaque treatment market with its IVL technology. This positions Shockwave Medical as a key player in the cardiology devices sector, offering a novel solution to a widespread clinical challenge, which could lead to significant market penetration and growth. X. $TMDX (TransMedics) • Competitive Advantage: Targets a critical healthcare need with its Organ Care System (OCS), which stands to revolutionize organ transplant logistics. By potentially increasing the viability of donor organs, TransMedics addresses a significant gap in transplant medicine, opening up market opportunities in a high-need area. These revised points focus more on the business impact, market positioning, and specific sector appeal of each company.  XXXXXX engagements  **Related Topics** [stocks technology](/topic/stocks-technology) [ozempic](/topic/ozempic) [all the](/topic/all-the) [$6753t](/topic/$6753t) [$insp](/topic/$insp) [coins layer 2](/topic/coins-layer-2) [insp inspire medical systems](/topic/insp-inspire-medical-systems) [$issc](/topic/$issc) [Post Link](https://x.com/StockSavvyShay/status/1722613501502603515)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Shay Boloor @StockSavvyShay on x 198.7K followers
Created: 2023-11-09 13:53:58 UTC
Medtech stock have recently seen a sharp drawdown due to all the noise regarding the anti-obesity drug Ozempic -- let's delve into my "Starting 5' names along with their competitive moats & examine where they stand based on 2025 FCF multiple🤔
X. $INSP (Inspire Medical Systems) • Competitive Advantage: Dominates the niche market of sleep apnea treatment through innovative technology. Their Inspire therapy, a unique neurostimulation device, directly targets the patient market dissatisfied with or ineligible for CPAP machines, creating a significant market opportunity in sleep disorder treatment.
X. $ISRG (Intuitive Surgical) • Competitive Advantage: Leads in the robotic-assisted surgery market with its da Vinci Surgical System. This technology offers hospitals and surgical centers a competitive edge through enhanced precision and minimally invasive procedures, leading to better patient outcomes and potentially shorter hospital stays.
X. $PGNY (Progyny) • Competitive Advantage: Carves a unique niche in the fertility benefits management sector. By offering integrated fertility and family planning services, Progyny appeals to a growing corporate client base seeking to provide comprehensive health benefits, thereby tapping into a growing market demand for inclusive healthcare benefits.
X. $SWAV (Shockwave Medical) • Competitive Advantage: Innovates in the calcified plaque treatment market with its IVL technology. This positions Shockwave Medical as a key player in the cardiology devices sector, offering a novel solution to a widespread clinical challenge, which could lead to significant market penetration and growth.
X. $TMDX (TransMedics) • Competitive Advantage: Targets a critical healthcare need with its Organ Care System (OCS), which stands to revolutionize organ transplant logistics. By potentially increasing the viability of donor organs, TransMedics addresses a significant gap in transplant medicine, opening up market opportunities in a high-need area. These revised points focus more on the business impact, market positioning, and specific sector appeal of each company.
XXXXXX engagements
Related Topics stocks technology ozempic all the $6753t $insp coins layer 2 insp inspire medical systems $issc